We are live on ! Find out more
SGRY icon

Surgery Partners

138 hedge funds and large institutions have $2.19B invested in Surgery Partners in 2022 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 58 increasing their positions, 33 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

76% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 33

62% more call options, than puts

Call options by funds: $9.57M | Put options by funds: $5.89M

1.67% more ownership

Funds ownership: 102.75%104.42% (+1.7%)

5% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 22

1% more funds holding

Funds holding: 137138 (+1)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

18% less capital invested

Capital invested by funds: $2.66B → $2.19B (-$472M)

Holders
138
Holders Change
+1
Holders Change %
+0.73%
% of All Funds
2.38%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
23
Increased
58
Reduced
33
Closed
22
Calls
$9.57M
Puts
$5.89M
Net Calls
+$3.68M
Net Calls Change
+$3.17M
Name Holding Trade Value Shares
Change
Change in
Stake
BCI
1
Bain Capital Investors
Massachusetts
$1.15B
Fidelity Investments
2
Fidelity Investments
Massachusetts
$316M +$183K +5,741 +0%
ClearBridge Investments
3
ClearBridge Investments
New York
$103M +$1.57M +49,191 +1%
Vanguard Group
4
Vanguard Group
Pennsylvania
$88.3M +$732K +22,936 +0.6%
BlackRock
5
BlackRock
New York
$61M +$1.93M +60,462 +2%
DCP
6
Durable Capital Partners
Maryland
$49.9M +$14M +439,949 +26%
Invesco
7
Invesco
Georgia
$37.7M +$2.29M +71,574 +5%
Dimensional Fund Advisors
8
Dimensional Fund Advisors
Texas
$31.1M +$514K +16,103 +1%
T. Rowe Price Investment Management
9
T. Rowe Price Investment Management
Maryland
$24.3M +$33.1M +1,037,413 New
Victory Capital Management
10
Victory Capital Management
Texas
$21.6M -$4.43M -138,702 -13%
CC
11
Cannell & Co
New York
$20.9M +$17M +530,910 +147%
State Street
12
State Street
Massachusetts
$19.8M +$2.39M +74,801 +10%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$17.4M +$1.1M +34,492 +5%
HRCM
14
Hood River Capital Management
Florida
$16.1M +$411K +12,878 +2%
T. Rowe Price Associates
15
T. Rowe Price Associates
Maryland
$15M -$49.5M -1,549,488 -71%
Point72 Asset Management
16
Point72 Asset Management
Connecticut
$13.9M -$12.5M -391,147 -40%
ITP
17
Iron Triangle Partners
Connecticut
$12.9M +$9M +281,824 +105%
AAP
18
Ardsley Advisory Partners
Connecticut
$11.8M +$4.95M +155,000 +44%
WCM Investment Management
19
WCM Investment Management
California
$9.72M +$1.22M +38,111 +11%
N
20
Nuveen
North Carolina
$9.38M -$2.39M -74,898 -16%
Northern Trust
21
Northern Trust
Illinois
$8.91M -$29.2K -913 -0.2%
Marshall Wace
22
Marshall Wace
United Kingdom
$8.78M +$12M +375,466 New
CCP
23
Clough Capital Partners
Massachusetts
$8.57M +$4.55M +142,567 +64%
UBS AM
24
UBS AM
Illinois
$7.53M -$1.65M -51,536 -14%
Norges Bank
25
Norges Bank
Norway
$7.06M +$2.9M +90,920 +43%

SGRY Hedge Fund Activity: Q3 2022 in Review

138 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Surgery Partners (SGRY) for Q3 2022, worth a combined $2.19B — down 18% from $2.66B a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new SGRY positions and 22 closed out — a net gain of 1 holder — while 58 added to existing stakes and 33 trimmed.

The largest buyer was Cannell & Co, adding an estimated $17M. The largest seller was T. Rowe Price Associates, cutting an estimated $49.5M.

  • 138 institutional investors held Surgery Partners (SGRY) as of Q3 2022, up from 137 in Q2 2022.
  • Funds reported $2.19B of Surgery Partners stock for Q3 2022, down 18% quarter-over-quarter.
  • 23 funds opened new Surgery Partners positions in Q3 2022 and 22 closed out, a net change of +1 holder.
  • The largest Surgery Partners buyer in Q3 2022 was Cannell & Co, an estimated $17M added.
  • The largest Surgery Partners seller in Q3 2022 was T. Rowe Price Associates, an estimated $49.5M sold.

Based on aggregated 13F filings for Q3 2022.